Top compounds associated with response to CABP4


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.089 0.01
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.089 0.01
mRNA avrainvillamide CTRPv2 pan-cancer AAC 0.1 0.01
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.092 0.01
mRNA Doxorubicin GDSC1000 pan-cancer AAC -0.09 0.01
mRNA NVP-BEZ235 GDSC1000 pan-cancer AAC -0.085 0.01
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.09 0.01
mRNA Obatoclax Mesylate CTRPv2 pan-cancer AAC 0.083 0.01
mRNA N9-isopropylolomoucine CTRPv2 pan-cancer AAC 0.089 0.01
mRNA RAF265 CCLE pan-cancer AAC -0.12 0.01
Download CSV